Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00387725
Registration number
NCT00387725
Ethics application status
Date submitted
11/10/2006
Date registered
13/10/2006
Date last updated
21/11/2014
Titles & IDs
Public title
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents
Query!
Scientific title
A Randomized, Observer-blinded, Parallel-group, Active-control, Phase ½ Trial Of The Safety, Immunogenicity, And Tolerability Of 20 Mg, 60 Mg, And 200 Mg Of Meningococcal Group B Rlp2086 Vaccine In Healthy Children And Adolescents Aged 8 To 14 Years
Query!
Secondary ID [1]
0
0
B1971006
Query!
Secondary ID [2]
0
0
6108A1-501
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Healthy
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Other interventions - rLP2086
Other interventions - rLP2086
Other interventions - rLP2086
Other interventions - rLP2086
Experimental: Group A - 20ug Experimental
Experimental: Group 2 - 60ug Experimental
Experimental: Group 3 - 200ug Experimental
Active Comparator: Group 4 - Active comparator
Other interventions: rLP2086
Vaccine administered at 0, 1, and 6 months
Other interventions: rLP2086
Vaccine administered at 0, 1, and 6 months
Other interventions: rLP2086
Vaccine administered at 0, 1, and 6 months
Other interventions: rLP2086
Vaccine administered at 0, 1, and 6 months
Query!
Intervention code [1]
0
0
Other interventions
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Percentage of Participants With Seroconversion in rLP2086 Specific Serum Bactericidal Assay (SBA) Titer 1 Month After Dose 2
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
1 month after Dose 2
Query!
Primary outcome [2]
0
0
Percentage of Participants With Seroconversion in rLP2086 Specific SBA Titer 1 Month After Dose 3
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
1 month after Dose 3
Query!
Primary outcome [3]
0
0
Percentage of Participants With at Least One Adverse Event (AE)
Query!
Assessment method [3]
0
0
Query!
Timepoint [3]
0
0
Dose 1 up to 1 month after Dose 3
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria
- Aged 8 to 14 years at the time of enrollment.
- Healthy male or female subjects
- Negative urine pregnancy test for female subjects
Query!
Minimum age
8
Years
Query!
Query!
Maximum age
14
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion Criteria
- Prior vaccination with a meningococcal B vaccine
- Prior meningococcal disease
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 2
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/11/2006
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/02/2008
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
127
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,WA
Query!
Recruitment hospital [1]
0
0
Sydney Children's Hospital - Randwick
Query!
Recruitment hospital [2]
0
0
The Children's Hospital at Westmead - Westmead
Query!
Recruitment hospital [3]
0
0
Royal Children's Hospital - Herston
Query!
Recruitment hospital [4]
0
0
Princess Margaret Hospital for Children - Subiaco
Query!
Recruitment hospital [5]
0
0
Sir Albert Sakzewski Virus Research Centre (SASVRC) - Herston
Query!
Recruitment hospital [6]
0
0
Women's & Children's Hospital - North Adelaide
Query!
Recruitment hospital [7]
0
0
The Telethon Institute for Child Health Research - Subiaco
Query!
Recruitment hospital [8]
0
0
National Centre for Immunisation - Westmead
Query!
Recruitment hospital [9]
0
0
Department of Paediatrics and Child Health - Woden
Query!
Recruitment postcode(s) [1]
0
0
2031 - Randwick
Query!
Recruitment postcode(s) [2]
0
0
2145 - Westmead
Query!
Recruitment postcode(s) [3]
0
0
4006 - Herston
Query!
Recruitment postcode(s) [4]
0
0
6008 - Subiaco
Query!
Recruitment postcode(s) [5]
0
0
QLD 4006 - Herston
Query!
Recruitment postcode(s) [6]
0
0
SA 5006 - North Adelaide
Query!
Recruitment postcode(s) [7]
0
0
WA 6008 - Subiaco
Query!
Recruitment postcode(s) [8]
0
0
NSW 2145 - Westmead
Query!
Recruitment postcode(s) [9]
0
0
ACT 2606 - Woden
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Pfizer
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Study to evaluate the safety of an investigational meningitis vaccine and the immune response
to it in adolescents
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00387725
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Pfizer CT.gov Call Center
Query!
Address
0
0
Pfizer
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00387725
Download to PDF